Source link : https://newshealth.biz/health-news/fda-approves-new-drug-combo-for-tough-to-treat-ovarian-cancer/
The FDA approved relacorilant (Lifyorli) in combination with nab-paclitaxel (Abraxane) for the treatment of adults with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer. The combination of the selective glucocorticoid receptor antagonist and chemotherapy drug is indicated for patients who have received one to three prior lines of therapy, at least one of which […]
The post FDA Approves New Drug Combo for Tough-to-Treat Ovarian Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2026-03-25 20:09:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8